The equine events will initially take place at Rossdales Equine Hospital in Suffolk on 22nd October and at Ashbrook Veterinary Hospital in Cheshire on 5th December.
The roadshow will see a range of speakers renowned in the fields of equine veterinary medicine and QI share practical examples of improving outcomes for equine patients. Interactive workshops, real-life scenarios and case studies will show how QI techniques can be applied in practice to help teams prevent and respond to errors.
Confirmed speakers include Professor Debra Archer, Head of Equine Surgery and Professor in Equine Surgery at the University of Liverpool, Dr Alice Bird, Senior Clinical Anaesthetist at the Animal Health Trust and Dr Rachel Dean, Director of Clinical Research and Excellence in Practice, VetPartners.
President Elect of BEVA, Tim Mair, said: "There are many challenges to being an equine vet and running a successful equine practice. Even in large practices and equine hospitals, there is a risk that we operate in our own little bubble and assume that what we are doing is best practice, whereas in reality we could often do a better job.
"Clinical governance and quality improvement are tools that allow us to critically appraise our day-to-day work and identify ways in which we can continuously improve what we do – to the benefit of our patients and clients, as well as to ourselves."
The canine hip dysplasia roadshow will begin on 9th October in Gatwick, Surrey.
The event will review the condition prevalent in dogs, how best to investigate it and the available treatment options. Case examples will be used to show how the evidence can be evaluated, explain how to measure treatment outcomes and show how the use of checklists can help minimise potential errors.
It will be hosted by Mark Morton, RCVS Specialist in Small Animal Surgery (Orthopaedics). He said: "As vets we probably all undertake bits of QI on a day-to-day basis (whether we realise it or not!) but there is so much more we can do to embed it into our clinical work. Checklists, treatment guidelines and clinical auditing significantly improve our patient care and our outcomes.
"Whilst looking at hip dysplasia and the treatment options in detail, hopefully this roadshow will show how we can apply these ideas to improve our management of this condition as well as using them elsewhere.”
For the full programme of each event and to buy tickets, visit bit.ly/RCVSKnowledgeEvents.
Anyone interested in booking an RCVS Knowledge roadshow for their region can do so by contacting ebvm@rcvsknowledge.org.
Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.
The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.
Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.
Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.
Saliva was collected from 237 horses at the UK welfare charity, Bransby Horses, where EquiSal Tapeworm saliva testing was used to inform on anthelmintic administration over the course of a year. This diagnostic-led approach reduced the use of anti-tapeworm treatments by 86% compared to 6 monthly interval treatment strategies.
Austin Davis Biologics Ltd, the maker of the EquiSal Tapeworm saliva test, says it accurately diagnoses horses with a tapeworm infection, providing a low, borderline or moderate/high diagnosis.
Treatment is recommended for horses with a borderline or moderate/high result2.
In this latest study, the company says most horses diagnosed below the treatment threshold in the first saliva test remained below the threshold in the following two tests and 168 horses (71%) required no anti-tapeworm treatment at all.
Importantly, no increase in tapeworm infection prevalence was observed during the study period and only seven horses received treatment following all three saliva tests, suggesting that some horses are more susceptible to tapeworm infections.
The EVJ has prepared a podcast summarising the study findings here: https://evj.podbean.com/e/evj-of-the-hoof-podcast-no-1-march-2018-use-of-saliva-based-diagnostic-test-to-identify-tapeworm-infection-in-horses-in-the-uk/.
The study authors have also prepared a video abstract which can be viewed at https://vimeo.com/254338616 .
EquiSal saliva collection kits are available at trade prices to veterinary practices and SQPs. Contact enquiries@equisal.com or visit www.equisal.com for more information.
References
Katie, who works at Milbourn Equine, is now preparing with her horse Templar Justice, or TJ for short, to take part in what is widely acknowledged to be one of the world's most difficult equestrian events.
Last year, she competed at the Burghley Horse Trials and was voted "Amateur Rider of the Year" by Horse and Hound magazine.
Katie says she is determined to build on that success with a strong showing at Badminton: "The Burghley Horse Trials were amazing last year. I was so excited to be there and it went so well. To now be competing at Badminton will be an awesome experience.
"It’s one of only six 'five-star' equestrian events in the world and to compete there really is my dream come true."
The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.
The app allows trainers to store and share medical records and treatment plans, identify horses and, with a Bio Thermo chip, monitor temperature non-invasively.
In Ireland, the Irish Horse Racing Board (IHRB) requires every yard keep a Blue Book which has to be submitted monthly. In the Blue Book, every medication given to every horse is recorded, with the amounts, the name of the medication and its batch number all written in by hand. EquiTrace enables a trainer to email the blue book information direct from their mobile phone.
Vincent O’Connor, senior vet at Sycamore Lodge Equine Hospital on the Curragh, Ireland, says he has found the app very easy to use and particularly appreciates the way it suggests stand down periods required for intraarticular medication, where injections into different joints require different numbers of days withdrawal before competition. The experience of John Oxx, whose winner I Know I Can was disqualified because of a positive test for TCA (triamcinolone acetonide) on 2 July 2020, is a case in point. Dr Lynn Hillyer, IHRB Chief Veterinary Officer and Head of Anti-Doping, stated that the minimum recommended stand down time for TCA would be 14 days but added that the stifle is a complex joint and can be associated with longer excretion times than might be expected.
Kevin Corley said: "Keeping a horse’s identity straight might seem a simple thing, but when you have a yard where staff and horses can change frequently and records are kept in the office, far away from the stables and fields where the horses are, it is not as easy as you think. I remember a time when I was called out to genetically test four two year olds, each valued at over €50,000 because their registration documents had been lost before they had been filed and no one knew which one was which."
EquiTrace has been in trials in Ireland, England, USA, Sweden and Italy and Kevin says every yard which has tested the app has kept it in operation.
EquiTrace is a subscription service, with a basic service for $1/€1 per month per horse and a premium subscription at $2/€2 per month per horse. A scanner available from EquiTrace as a one-time cost is required to operate the system, ranging in price from €250 to €400 or USA $350 to $550.
EquiTrace works with all ISO-compliant microchips but some of the service offerings are dependent on the type of chip in the horse.
EquiTrace is available on Apple and Google appstores. Establishments with over 200 horses can contact EquiTrace directly to arrange a subscription. Current clients include DK Weld in Ireland, Ramsey Farm and Three Chimneys Farm in Kentucky, USA, Kinsale Stud in the UK and Avantea in Italy.
For more information, visit: https://equitrace.app
The Association is also encouraging horse owners to join in the celebrations by sharing birthday cakes with their vet or veterinary practice.
BEVA President Huw Griffiths said: "Our 60 faces initiative celebrates some of the many outstanding people who have left an indelible mark on the profession and whose actions complement BEVA’s work in championing progress and/or diversity."
The list of 60 faces, which were nominated by BEVA members, showcases people who have inspired, influenced and progressed the equine veterinary profession for the better.
The faces range from 16th Century humanist Thomas Blundeville to 21st Century social media entrepreneur Ebony Escalona.
Every day for a month, two faces will be released on BEVA’s social media channels.
Huw added: “It was a really tough challenge to whittle the list down to 60 people as all of the nominees were exceptional individuals.
“The list showcases some of the best-known names in the industry as well as some heroes whose stories are less well known or who have been consigned to history.
“It’s not a “Top 60”, nor are all the faces vets, but it does highlight the breadth of people who have impacted what we do.
"We hope you will enjoy reading about them and we hope our lovely clients will join in the celebrations during the week starting 18th November by sharing a celebratory piece of birthday cake with their cherished horse vet!”
You can see the 60 Faces here: https://www.beva.org.uk/60-Faces
If you're attending BEVA this September you can win a place on the CEVA-sponsored Equine Ski-PD break in January 2010, combining a couple of days of first class Continued Professional Development (CPD) with some excellent skiing in the Italian Alps.
The course runs from 13-17 January 2009 and the CPD will be spread over five sessions, equating to two-and-a-half days. Equine vets Jane Boswell, Henry Tremaine, Professor Bruce McGorum, Professor Peter Clegg and Dr Tim Brazil will cover the topics of tendonitis, wound management, ophthalmology, internal medicine and joint disease.
Skiing will be at Courmayeur, a traditional Alpine village on the Italian side of Mont Blanc, where all levels of ability, from beginners to experienced off-piste skiers, can be catered for.
To win your place, which includes flights and four nights b&b accommodation, simply visit the CEVA stand at BEVA and answer a questionnaire on Tildren®, CEVA's bisphosphonate-based treatment for equine bone disease, based on information provided via a short film loop that will be running on the stand.
For further information on equine Ski-PD contact the organisers: ben.mayes@equinevetpractice.co.uk or henry.tremaine@bristol.ac.uk
This year’s programme includes five live streams running in parallel throughout the conference with clinical research presentations also returning after the Covid-enforced hiatus.
The first plenary lecture will be presented by Pat McCue who will review events that have shaped current practice in equine reproduction before looking at what the future holds.
The second plenary lecture, being delivered by Celia Marr, will look at 'evidence in perinatology'.
David Lloyd, Congress Scientific Programme Chair, said: “Whilst we are sure most delegates will be clamouring to attend the lectures and discussions in Liverpool in person, the programme also includes a virtual stream available live online.
“Also, to help reduce our carbon footprint, we are holding one virtual session concurrently across all lecture theatres.
"Global leaders in the field of infectious disease, imaging, nursing, reproduction and sports medicine and rehabilitation, will present virtually to the lecture hall rather than travelling to the congress.
"This session will have 25 of the “best of the best” speakers, presenting and discussing topics that challenge us in practice.”
Early bird tickets for BEVA Congress are available from 28th February 2022.
Early bird BEVA member prices are £499 for vets and £187 for vet nurses for all three days (with concessions available for those in their first three years post graduation or on a lower salary).
Virtual tickets are £199 for vets and £40 for nurses.
BEVA has a 'peace of mind' bookings policy to reassure those who are concerned that the Covid-19 situation may change between booking their ticket and the event.
For more information, or to book, visit http://www.bevacongress.org/
A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.
The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.
Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.
Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.
Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).
The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.
The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.
The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.
Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.
According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.
Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."
The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.
Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."
Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.
Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis as well as to reduce post-surgical soft tissue reaction.
The new apple-flavoured version, which contains no added sugar, is presented in 1.5g sachets which are added to feed. The existing unflavoured product is still available as Equipalazone Original.
Dechra Brand Manager Emma Jennings said: “The new apple flavoured Equipalazone is the same tried and trusted popular product that vets have been using for many years but the enhanced apple flavour should improve compliance amongst even the fussiest of feeders.
"Equipalazone has been a best-selling treatment delivering powerful pain relief since we brought it to the market as the first microencapsulated phenylbutazone more than 45 years ago. The new apple flavoured presentation will give vets even more choice when it comes to providing pain relief and anti-inflammatory treatment for equine conditions."
For more information visit www.dechra.co.uk.
Two guides for equine veterinarians have just been produced by Hallmarq Veterinary Imaging covering the role of MRI in diagnosing lameness.
MRI Cases in the Standing Sedated Horse looks at fourteen cases from seven clinics in the Hallmarq user community. Compiled for Hallmarq by Dr Julien Olive DMV and complete with clinical MRI images, this 38 page booklet reviews the history, clinical examination, MRI examination, diagnosis, treatment and outcome of each case. The examples illustrate how MRI can enable a diagnosis to be made and a suitable course of treatment prescribed in difficult or ambiguous cases.
The second booklet, MRI Protocols for the Standing Sedated Horse, focuses on the procedures and terminology associated with MRI, from a brief description of the technology and the types of image that can be obtained, to a more detailed description of the methodology.
Hallmarq says that with 20 scanning centres now operating in the UK and Europe the ability now to refer selected cases for an MRI examination makes these booklets relevant to routine practice.
The booklets are available free of charge from Hallmarq for equine veterinarians and veterinary students, and they may be previewed on Hallmarq’s website.
Hallmarq Veterinary Imaging: (01483) 877812 or email info@hallmarq.net
BCF has announced the launch of the Medison Sonovet R3 portable ultrasound scanner.
BCF says the R3 is the next evolution of the Pico from Medison which is ideal for both equine and small animal vets. It is now more compact with a robust design with enhanced image quality and improved frame rate, and even at a lower price.
Graham Howe, Partner at Stow Veterinary Surgeons in Gloucestershire has one of the new machines. He said: "We chose the Medison R3 for several reasons. The R3 is an excellent quality machine at the right price and provides excellent value for money. We wanted Doppler and the R3 provides this without breaking the bank.
"The scanner has increased our diagnostic capabilities and enabled us to diagnose increasingly subtle lesions in small animal anatomy.
"We also knew from previous experience with previous with an ultrasound scanner and digital X-ray machine that we could rely on BCF for support."
For more information visit http://www.bcftechnology.com/, or call +44 (0)1506 460023 to arrange a demonstration.
The British Veterinary Association has welcomed the European Commission's Action Plan on Antimicrobial resistance (AMR), launched yesterday on the eve of European Antibiotic Awareness Day.
The Action Plan sets out 12 actions:
However, the association has expressed concern that the Commission has given only qualified support for new antimicrobials for veterinary use. Carl Padgett, President of the BVA, said: "There is much to be applauded in this action plan. In particular the BVA supports the calls for more and better coordinated research, more responsible use of antimicrobials in human and veterinary medicine, and the development of diagnostic tools to quickly and accurately identify the right drug for the right bug.
"The use of antimicrobials in the treatment and control of animal diseases is essential and the BVA supports the strong messages in this plan. Any option for managing AMR must be firmly rooted in sound scientific assessment of the risk.
"While the report recognises the difficulties that have led to the hampering of research into new antimicrobials for veterinary use, we are concerned that there is only qualified support from the Commission for the development of these new medicines for animal use.
"Research into new antimicrobials should be supported in both human and veterinary medicine. We need to ensure the creation of a more predictable regulatory environment to encourage new products for animals to be brought to the market.
"Finally, while the BVA supports the need for a new regulatory framework any new regulations must not impede the ability of veterinary surgeons to prescribe and dispense medicines according to their clinical judgement."
Meanwhile, Jill Moss of the Bella Moss Foundation added her voice to those calling for responsible use of antibiotics, highlighting recent research from the Royal Veterinary College that has established a clear link between pets with MRSA infection and human hospital-associated MRSA. What is less widely recognised, she says, is that resistant bacteria can be passed from human to animal.
The charity is now calling on health and veterinary professionals to work together to achieve a reduction in resistant infections by raising awareness and promoting the responsible use of antibiotics.
The company says the new product has been launched in response to demand from UK equine veterinary surgeons specialising in dentistry
Hexarinse for Horses is presented as a palatable, mint-flavoured, ready-to-use formulation in a five litre container.
Virbac says the antibacterial action of chlorhexidine supports the maintenance of oral health after dental procedures and may aid the management of periodontal disease, oral inflammation and the management of peripheral caries.
For further information, speak to your local Virbac territory manager or contact Virbac Limited on: 01359 243243 or enquiries@virbac.co.uk.